Today in Business
SEE OTHER BRANDS

Your business news from the world

Today in Business: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Business.

Press releases published on May 9, 2025

EAACI Hong Kong Allergy School 2025: Mercu Tanda dalam Pendidikan Alergi Global

EAACI Hong Kong Allergy School 2025: Mercu Tanda dalam Pendidikan Alergi Global

ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …

EAACI Hong Kong Allergy School 2025: Ein Meilenstein in der globalen Allergieaufklärung

EAACI Hong Kong Allergy School 2025: Ein Meilenstein in der globalen Allergieaufklärung

ZÜRICH, May 09, 2025 (GLOBE NEWSWIRE) -- Die European Academy of Allergy …

EAACI Hong Kong Allergy School 2025: Um Marco na Educação Global sobre Alergias

EAACI Hong Kong Allergy School 2025: Um Marco na Educação Global sobre Alergias

ZURIQUE, May 09, 2025 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia Clínica (EAACI), em parceria com o Instituto de Alergia de Hong Kong (HKIA), tem a alegria de anunciar a primeira edição da EAACI Hong Kong Allergy School. Este …

École d’allergologie de l’EAACI à Hong Kong 2025 : un modèle pour l’enseignement mondial de l’allergologie

École d’allergologie de l’EAACI à Hong Kong 2025 : un modèle pour l’enseignement mondial de l’allergologie

ZURICH, 09 mai 2025 (GLOBE NEWSWIRE) -- L’Académie européenne d’allergologie et d’immunologie clinique (The European Academy of Allergy …

2025 年 EAACI 香港过敏学校:全球过敏教育的里程碑

2025 年 EAACI 香港过敏学校:全球过敏教育的里程碑

苏黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 欧洲过敏和临床免疫学学会(European Academy of Allergy …

EAACI 香港過敏學校 2025:全球過敏教育的里程碑

EAACI 香港過敏學校 2025:全球過敏教育的里程碑

蘇黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 歐洲過敏及臨床免疫學會 (EAACI) 與香港過敏科醫學會 (HKIA) 攜手合作,隆重宣布首屆 EAACI 香港過敏學校開幕。 這項重要的里程碑活動將於香港這個充滿活力的亞洲國際都會展開,東方與西方在此交匯,創新與傳統碰撞,全球思潮匯聚一堂。 2025 年過敏學校以「東方遇見西方」為主題,朝着推動過敏及臨床免疫學跨洲合作邁出了大膽的一步。 …

EAACI Hong Kong Allergy School 2025: ความสำเร็จครั้งสำคัญด้านการศึกษาโรคภูมิแพ้ระดับโลก

EAACI Hong Kong Allergy School 2025: ความสำเร็จครั้งสำคัญด้านการศึกษาโรคภูมิแพ้ระดับโลก

ซูริก, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …

Anika Reports First Quarter 2025 Financial Results

Anika Reports First Quarter 2025 Financial Results

First Quarter 2025 Commercial Channel revenue up 18% Integrity™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating …

uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress

~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in …

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …

Top Tribal Loans with Guaranteed Approval for Bad Credit – IOnline Payday Loans

Top Tribal Loans with Guaranteed Approval for Bad Credit – IOnline Payday Loans

SHERIDAN, Wyo., May 09, 2025 (GLOBE NEWSWIRE) -- If your credit score isn’t perfect, the search for financial assistance can seem to be very frustrating— but it doesn’t have to be. Tribal loans direct lenders guaranteed approval have proven to be a …

Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33 …

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series

WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Aclaris’ Chief …

Onex Reports First Quarter 2025 Results

Onex Reports First Quarter 2025 Results

All amounts in U.S. dollars unless otherwise stated TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2025. “Onex continues to make progress and is benefitting …

OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 28th Annual …

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …

Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update

Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update

Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) new …

U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

HOLMDEL, N.J. and WASHINGTON, May 09, 2025 (GLOBE NEWSWIRE) -- The U.S. Small Business Administration has announced that Renaissance Global Services (RGS), a New Jersey-based Service-Disabled Veteran-Owned Small Business, has been awarded the National …

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing …

Supremex Reports Voting Results from its Annual General Meeting

Supremex Reports Voting Results from its Annual General Meeting

MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced the voting results …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service